Gaithersburg, MD, United States of America

David Kenneth Spencer

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: David Kenneth Spencer: Innovator in Therapeutic Scaffolds

Introduction

David Kenneth Spencer is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of therapeutic scaffolds. With a total of 3 patents, Spencer's work focuses on innovative methods for treating autoimmune diseases.

Latest Patents

Spencer's latest patents include groundbreaking inventions such as "Methods of administering a composition comprising a Tn3 scaffold and a CD40L-specific monomer." This invention provides Tenascin-3 FnIII domain-based scaffolds that specifically bind to CD40L. The engineered variants exhibit increased affinity for the target, making them valuable as prophylactic, diagnostic, or therapeutic agents, especially for conditions like systemic lupus erythematosus (SLE) and other autoimmune diseases. Another patent, "Nucleic acids encoding a Tn3 scaffold comprising a CD40L-specific monomer subunit," further emphasizes his focus on engineered scaffolds for therapeutic applications.

Career Highlights

David Kenneth Spencer is currently associated with Viela Bio, Inc., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the field of therapeutic innovations.

Collaborations

Spencer collaborates with esteemed colleagues such as Anthony Coyle and Thomas Thisted, contributing to a dynamic research environment that fosters innovation.

Conclusion

David Kenneth Spencer's contributions to the field of biomedical engineering through his patents and collaborations highlight his commitment to advancing therapeutic solutions for autoimmune diseases. His innovative work continues to pave the way for future developments in this critical area of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…